Health ❯ Healthcare ❯ Research and Development

Clinical Trials

Innovative Therapies Preclinical Testing Alzheimer's Treatments Vaccine Development Cancer Vaccines Transplantation Studies Next-Generation Therapies Antibody-based Medicines Robotic Technology Preclinical Studies

FDA Seeks Public Input to Repurpose Approved Drugs for Hard-to-Treat Conditions

The effort signals a push to tap nontraditional evidence to speed label updates for underserved patients.

Home Blood Test and Online Checks Flag Alzheimer’s Risk in Small Study

LEO Pharma to Acquire Replay in $50 Million Gene-Therapy Deal

Germany to Cover Four Off-Label Drugs for Long Covid Under Statutory Insurance

Milan’s Besta Hospital Deploys Rare Exablate Prime to Speed MRI‑Guided Brain Ultrasound

Eli Lilly’s Tirzepatide Surge Collides With Rich-Valuation Concerns

Driehaus and Deerfield Lift Praxis Stakes in Q4, SEC Filings Show

Novartis Licenses SciNeuro’s Brain‑Shuttle Alzheimer’s Antibodies in Deal Worth Up to $1.7 Billion

Vaccimel, Argentina's Melanoma Immunotherapy, Enters Commercial Use

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

India Approves Donanemab for Early Alzheimer’s as Lilly Targets 2026 Launch

Gene-Edited Pig Liver Functions in Living Patient for 38 Days in First-in-Human Transplant

Intranasal Antibody Cuts Mugwort Allergy in Mice, Paving Way for Human Trials

UK Administers First Teplizumab Immunotherapy to Adult Type 1 Diabetes Patient

UC Irvine’s Iris Valve Achieves Key Preclinical Milestones

NICE Bars New Alzheimer’s Antibodies from NHS Over Cost and Capacity

Innovative Implant Detects and Reverses Opioid Overdoses